Study |
N of patients |
Target area |
Stimulation parameters |
N of pulses/ session |
N of sessions |
Outcome measure |
Mally& Stone, [64] |
49 |
Vertex |
1 Hz – 30-60% MO |
30 x 2 |
10 |
UPDRS |
Mally& Stone, [65] |
10 |
Vertex |
1 Hz – 20% MT |
30 |
20 |
UPDRS; GRCT |
Shimamoto et al., [66] |
18 |
Frontal |
0.2 Hz – 700 V |
60 |
8 |
UPDRS-III |
Ikeguchi et al., [67] |
12 |
Frontal; occipital cortex |
0.2 Hz – 70% MO |
60 |
6 |
UPDRS-III ADL |
Okabe et al., [36] |
85 |
Occipital cortex |
0.2 Hz – 110% RMT |
100 |
8 |
UPDRS-III |
Sedlackova et al., [61] |
10 |
PMd; occipital cortex |
10 Hz – 100% RMT |
1350 |
3 |
UPDRS-III |
Arias et al., [68] |
18 |
Vertex |
1 Hz – 90% RMT |
100 |
10 |
UPDRS-III |
|
Table 4: rTMS studies in PD: Other target areas. rTMS, repetitive Transcranial Magnetic Stimulation; PD, Parkinson’s Disease; PMd, dorsal Premotor Cortex; PFC, Prefrontal Cortex; Hz, Hertz; MO, maximum output; UPDRS (III), Unified Parkinson’s Disease Rating Scale (Section III); GRCT, graded rating clinical test; ADL, Activities of Daily Living. |